A 65-Year-Old Man with Prostate Cancer and a 77-Year-Old Man with Prostate Cancer

Specialist Brian Helfand, MD, PhD, reviews the case of a 65-year-old man with prostate cancer and shares insight on strategies to monitor for recurrence.

A comprehensive review of imaging modalities available to patients with prostate cancer who are suspected of recurrence.

Following his review of available imaging modalities, Brian Helfand, MD, PhD, considers which scans are most appropriate based on patient and disease factors.

A brief discussion on how selection of imaging should be approached for patients receiving androgen deprivation therapy (ADT) for prostate cancer.

Moving on to the second patient case of prostate cancer, Brian Helfand, MD, PhD, shares context for negative imaging results in this setting.

Expert perspective on next steps for physicians and patients following a negative imaging result when recurrent prostate cancer is suspected.

Closing out his review of imaging modalities in the setting of prostate cancer, Brian Helfand, MD, PhD, looks toward future evolutions in detection and treatment.